BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6305295)

  • 1. Disease due to cytomegalovirus and its long-term consequences in renal transplant recipients. Correlation of allograft survival with disease due to cytomegalovirus and rubella antibody level.
    Luby JP; Ware AJ; Hull AR; Helderman JH; Gailiunas P; Butler S; Atkins C
    Arch Intern Med; 1983 Jun; 143(6):1126-9. PubMed ID: 6305295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
    Marker SC; Howard RJ; Simmons RL; Kalis JM; Connelly DP; Najarian JS; Balfour HH
    Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
    Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
    Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK; Peiris JS; Taylor CE; Warwicker P; Jarrett RF; Madeley CR
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The problem of cytomegalovirus infection in renal allograft recipients.
    Kurtz JB; Thompson JF; Ting A; Pinto A; Morris PJ
    Q J Med; 1984; 53(211):341-9. PubMed ID: 6091169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of rapid methods of detecting cytomegalovirus in the blood of renal transplant recipients in relation to patient and graft survival.
    Eriksson BM; Wirgart BZ; Claesson K; Tufveson G; Magnusson G; Tötterman T; Grillner L
    Clin Transplant; 1996 Dec; 10(6 Pt 1):494-502. PubMed ID: 8996769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients.
    John GT; Manivannan J; Chandy S; Peter S; Fleming DH; Chandy SJ; Balakrishnan N; Krishnamurthy K; Kirubakaran MG; Jacob CK
    Transplant Proc; 2005 Dec; 37(10):4303-5. PubMed ID: 16387103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation.
    Simmons RL; Matas AJ; Rattazzi LC; Balfour HH; Howard JR; Najarian JS
    Surgery; 1977 Nov; 82(5):537-46. PubMed ID: 199956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
    Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rubella antibodies and adverse events late after renal transplantation.
    Luby JP; Ware AJ; Vergne-Marini P; Stastny P; Hull AR
    Arch Intern Med; 1979 Jan; 139(1):33-5. PubMed ID: 367306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between cytomegalovirus infection and the so-called intolerance to azathioprine in renal transplantation].
    Ancona G; Dean P; Muolo A; Galvani E; Zanuso C; Gulino S; Confortini P
    Minerva Chir; 1980 May; 35(10):731-4. PubMed ID: 6256686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
    Boobes Y; Al Hakim M; Dastoor H; Bernieh B; Abdulkhalik S
    Transplant Proc; 2004; 36(6):1841-3. PubMed ID: 15350493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.